Jump to main content
Jump to site search

Issue 3, 2016
Previous Article Next Article

Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides

Author affiliations

Abstract

The drug development of siRNA has been seriously hindered by the lack of an effective, safe and clinically applicable delivery system. The cyclic NGR motif and its isomerization product isoDGR recruit CD13 and integrin as their specific receptors, both of which are overexpressed by tumor and neovascular cells. In this study, a bi-functional peptide, named NGR-10R, was designed and tested for siRNA delivery in vitro and in vivo. Through the formation of peptide/siRNA nanoparticles, RNase resistance was greatly enhanced for the siRNAs. Both FACS and confocal assays revealed that the peptide/siRNA complexes were effectively internalized by MDA-MB-231 cells. Gene silencing assays indicated that anti-Lamin A/C siRNA delivered by NGR-10R robustly repressed gene expression in MDA-MB-231 and HUVEC (a CD13+vβ3+ cell). Importantly, the siRNAs were efficiently delivered into tumor tissues and localized around the nuclei, as revealed by in vivo imaging and cryosection examination. In summary, NGR-10R not only efficiently delivered siRNAs into MDA-MB-231 cells in vitro but also delivered siRNAs into tumor cells in vivo, taking advantage of its specific binding to CD13 (neovascular) or αvβ3 (MDA-MB-231). Therefore, the NGR-10R peptide provides a promising siRNA delivery reagent that could be used for drug development, particularly for anti-tumor therapeutics.

Graphical abstract: Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides

Back to tab navigation

Supplementary files

Publication details

The article was received on 02 Oct 2015, accepted on 31 Dec 2015 and first published on 19 Jan 2016


Article type: Paper
DOI: 10.1039/C5BM00429B
Author version
available:
Download author version (PDF)
Citation: Biomater. Sci., 2016,4, 494-510

  •   Request permissions

    Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides

    Y. Huang, Q. Cheng, X. Jin, J. Ji, S. Guo, S. Zheng, X. Wang, H. Cao, S. Gao, X. Liang, Q. Du and Z. Liang, Biomater. Sci., 2016, 4, 494
    DOI: 10.1039/C5BM00429B

Search articles by author

Spotlight

Advertisements